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Abstract
Background: The Taiwanese government increased financial subsidies for smoking cessation services in 2012. We
aimed to evaluate the effects of this new policy on smoking cessation services from the physician’s perspective.
Methods: This was a cross-sectional nationwide survey. Physicians who provided smoking cessation services for more
than ten patient encounters in the preceding year of the new policy (February 2011 to March 2012) were recruited.
The questionnaire was developed by two experts and was validated by a committee consisting of 11 delegates.
Results: We sent a total of 1,319 questionnaires. The response rate was 45.9 %. The majority of respondents were male
(88.4 %), middle-aged (65.3 %), and worked as family physicians (56.1 %). Most physicians agreed that the new policy
had increased the number of patients seeking smoking cessation, increased patients’ willingness to adopt
pharmacotherapy, helped physicians to prescribe medications, improved patients’ adherence to medications, and
improved quality of care. These changes were most prominent in medical centers. Changes in the practice of the 5As
(ask, advise, assess, assist, arrange) were moderate. Among different medical settings, the most significant change was
an increase in the expenditure on smoking cessation medications.
Conclusions: The new subsidization policy in Taiwan has improved smoking cessation services. Overall, physicians
reported positive effects of the new policy. Further study is warranted to evaluate the long-term influence of the policy.
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Background
Tobacco use has reached epidemic levels around the
world, resulting in a worldwide increase in tobacco-
related deaths and disabilities [1]. In 2012, smoking rates
for men and women in Taiwan were 32.7 and 4.3 %, re-
spectively [2]. Wen and colleagues report that smoking-
related diseases are responsible for a loss of 22 years’ life
expectancy in Taiwanese smokers [3].
There is strong evidence to support a need for tobacco
control programs to decrease the health and economic
burden of smoking [4]. An important strategy is to offer
help to quit tobacco use [5]. Article 14 of the World Health
Organization Framework Convention on Tobacco Control
(WHO FCTC) states that national policy or health insur-
ance systems should make medications accessible and free,
or at an affordable cost [6]. In the International Tobacco
Control 4 Country Survey, under national financial policy
(English Stop Smoking Services), U.K. smokers were more
likely to achieve 28-day abstinence than those in Australia,
Canada, and the United States [7].
The Taiwanese government has taken multiple ap-
proaches to reduce tobacco demand in different phases
[8]. Since 2002, a tobacco health and welfare surcharge
of NT$5 (US$0.14) per pack of cigarettes has been im-
posed [9], and subsidized tobacco cessation services that
provide pharmacotherapy and brief counseling by physi-
cians have been initiated [10]. Following the amendment
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of the Tobacco Hazards Prevention Act in 2009, smoking
has been prohibited in virtually all indoor areas [11]. Over
the years, the specialties providing smoking cessation ser-
vices have evolved from family physicians and internists
only to all medical specialties, including pediatrics, obstet-
rics, and psychiatry. Many Taiwanese physicians have been
trained to help patients quit smoking, and smoking cessa-
tion has become a popular service [12]. The findings of
the 2012 Adult Smoking Behavior Survey in Taiwan re-
vealed that half of the responding smokers (50.7 %) had
been urged by medical professionals to quit smoking [2].
The abstinence rates of the outpatients in one medical
center were 99.7, 49.2, 37.7, 30.2, and 22.7 %, at 1, 3, 6, 12,
and 36 months, respectively [9].
By 2012, smoking cessation services were available at
2,152 contracted medical institutions with a geographic
coverage rate of 97 % [2]. The physician fee was paid by
the Health Promotion Administration (HPA) at a rate of
NT$250 (US$8.33) per visit. Patients were responsible
for a weekly out-of-pocket prescription co-payment of
NT$550 to NT$1,250 (US$18.33 to US$21.67) [2]. How-
ever, this cost was still a potential hurdle for people on
low incomes who intended to quit smoking.
To remove the economic barrier of smoking cessation
service and lessen health inequality, the government
started the Second-generation Cessation Payment
Scheme (SCPS) in March 2012. The new policy is as fol-
lows: the patient’s co-payment is 20 % of the total medica-
tion cost and has an upper limit of NT$200 (US$6.67).
The upper limit allows physicians to prescribe more ex-
pensive medications such as varenicline without being
concerned about cost. Full subsidies are provided for
smokers from low-income households. To encourage
tracking of the smoking status of the patients, case man-
agement fees are also subsidized at NT$100 (U$3.33) per
treatment course. Case managers have to call patients by
telephone and report 7-day point prevalence rates at 3-
and 6-months. The new policy also includes some other
changes. The maximum length of prescription is extended
from 2 to 4 weeks, and cessation services are no longer
restricted to outpatients but also serve inpatients and
emergency room patients.
After SCPS, the number of smoking cessation patients
increased by 41 %, from 83,724 during the year before its
implementation to 117,989 during the year after implemen-
tation [13]. The 7-day point prevalence rate at 6 months in-
creased from 22.8 to 28.0 % [14]. However, we don’t know
the extent of these changes, such as the patient’s willingness
to adopt pharmacotherapy, patient’s adherence to medica-
tion, and the quality of care. We also don’t know the atti-
tude of the physicians (positive or negative to the new
policy), the barriers of implementation, and the change of
the physicians’ practice. In this study, we aimed to evaluate
the impact of SCPS from the perspectives of physicians.
Methods
Study design
We conducted a cross-sectional nationwide questionnaire-
based survey.
The participants
We recruited 1,319 physicians who provided smoking
cessation services for more than ten patient encounters
in the preceding year of the new policy (February 2011
to March 2012). The physicians’ roster was provided by
the HPA, Ministry of Health and Welfare, Taiwan.
The questionnaire
The questionnaire was designed by two family physicians
specializing in smoking cessation (FR Guo and LY
Hung). An expert committee composed of 11 delegates
from the Taiwan Association of Family Medicine, Taiwan
Society of Internal Medicine, Taiwanese Society of
Psychiatry, and HPA then collectively reviewed the ques-
tionnaire. A five-point Likert scale was used to encode
the content validity of the questionnaire according to
the importance and appropriateness of each item. The
criterion of an average score of four or above was used
to select the final items.
The questionnaire included five domains: patient
changes, physicians’ attitudes towards the new policy,
barriers to implementation, changes in practicing the
5As (ask, advise, assess, assist, arrange), and institutional
changes. Each domain was composed of five simple
choice questions. Except for the domain of institutional
changes, which were yes/no questions, the other four
domains were five-point Likert scale choices. For these
Likert-scaled questions, the choices were recorded as
scores. A score of one meant strong disagreement while
five meant strong agreement. The average score reflected
the level of physicians’ agreement with the statement. By
combining the scores of the five questions in each do-
main, we obtained a summation index of each domain
(including patient changes, physician attitudes, possible
barriers, and practice of the 5As).
The process of sending the questionnaires and collecting
responses
We mailed the questionnaires to each physician’s prac-
ticing institution in July 2012. Physicians had to sign an
informed consent before study participation. To improve
the response rate, participants could respond in one of
three ways: in a pre-paid return envelope, by facsimile,
or by e-mail. We examined the questionnaires 2 weeks
later and resent the same questionnaire in August to
non-respondents. After collecting the last questionnaires
on September 20, 2012, we started data analysis. Ques-
tionnaires without a physician’s signature were excluded.
A questionnaire was considered “valid” if it had less than
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three unanswered questions. A small gift of appreciation,
a LED lamp, was sent to respondents who provided valid
questionnaires.
Statistical analysis
Descriptive analysis was used for baseline characteristics
and variables in the questionnaire. We examined the dif-
ference between respondents and non-respondents using
a chi-square test. For multivariate analysis, we used
baseline characteristics as independent variables and
summation indexes as dependent variables. The correla-
tions were examined by multiple regression models. To
evaluate the institutional changes in different levels of
medical settings, we further stratified our data according
to settings, i.e., medical centers, regional hospitals, local
hospitals, and primary care facilities. Chi-square tests
were used to examine the differences. A p-value <0.05
for two-tailed tests was considered statistically significant.
SPSS for Windows (IBM Company, New York, USA) was
used for statistical analysis.
Ethical approval
This study was approved by the institutional review
board (IRB) of Cardinal Tien Hospital, Taiwan. Only
physicians who signed the informed consents were in-
cluded in the analysis. Taiwan Association of Family
Medicine is responsible for the certification of physi-
cians and the researchers of this study have accessed
the certification records. The researchers did not access
patient records.
Results
We sent a total of 1,319 questionnaires. The response
rate was 45.9 % (n = 605). The majority of the question-
naires were received by mail (n = 429, 70.9 %), followed
by fax (n = 162, 26.8 %), and e-mail (n = 14, 2.3 %). Com-
pared to non-respondents, respondents tended to be
older, mostly family physicians, and mainly practicing in
primary care settings (Table 1). The majority of respon-
dents practiced in private institutions (n = 465, 76.9 %).
Table 2 presents the impact of the new subsidization
policy to smoking cessation services. Most physicians
agreed or strongly agreed that the new policy increased
the number of patients engaging in smoking cessation
treatment (85.3 %), and increased patients’ willingness to
adopt pharmacotherapy (55.0 %). For physicians’ atti-
tudes, more than 50 % of respondents agreed or strongly
agreed with all five items, including that the new policy
was an improvement over the previous policy. The qual-
ity of care was also deemed to have improved. For pos-
sible barriers to the implementation of the new policy,
the majority of physicians were neutral, and less than
50 % agreed or strongly agreed with all five items. It was
most difficult to track the abstinence rates of patients
(39.8 %) and least difficult to use the information system
(24.0 %). Regarding the practice of the 5As, changes fol-
lowing the introduction of the new policy were moder-
ate. The percentages of physicians who agreed or
strongly agreed that the change in practice of the 5As
was improved ranged from 44.2 % (for arrange) to
48.7 % (for assist), respectively.
We used multiple regression models to evaluate the
correlation between baseline characteristics and four
summation indexes (Table 3). Medical centers were the
institution type most associated with patient changes,
physician attitudes and practice of the 5As. Age and the
specialty of family medicine were also associated with
patient changes. The former had an inverse association
while the latter had a positive association. No other vari-
able of baseline characteristics was significantly associated
with the summation indexes.
Table 4 presents institutional changes at different
levels of medical setting. The most prominent change
observed was an increase in expenditure on smoking
cessation medications (52.9 %). This change was consist-
ent across different levels of settings. Only a few institu-
tions reported an increase in smoking cessation personnel;







n (%) n (%)
Gender
Male 535 (88.4) 628 (88.0) 0.79
Female 70 (11.6) 86 (12.0)
Age (years)
39 and under 103 (17.0) 162 (22.7) 0.001
40-59 395 (65.3) 470 (65.8)
60 and over 107 (17.7) 82 (11.5)
Specialty
Family medicine 339 (56.1) 324 (47.7) 0.009
Internal medicine 142 (23.5) 166 (24.4)
Psychiatry 10 (1.7) 17 (2.5)
Others 114 (18.8) 172 (25.3)
Practicing institution
Medical center 25 (4.1) 40 (5.6) <0.001
Regional hospital 61 (10.1) 190 (26.7)
Community hospital 56 (9.3) 11 (1.5)
Primary care setting 463 (76.5) 471 (66.2)
Smoking status
Non-smoker 531 (87.8) - -
Ex-smoker 68 (11.2) - -
Current smoker 6 (1.0) - -
Wu et al. BMC Public Health  (2016) 16:415 Page 3 of 7
however, medical centers had significantly greater in-
creases in the numbers of physicians, case managers,
and professional counselors providing smoking cessa-
tion services.
Comparing physicians’ responses from different
medical settings (data not shown), physicians at medical
centers seemed to take a more positive attitude towards
the new policy. However, they also encountered more
difficulties in providing services to inpatients and
emergency room patients.
For the reliability of the questionnaire, the Cronbach’s
Alpha of the domain of patient changes is 0.81, physician’s
attitudes is 0.92, barriers to implementation is 0.69, and
changes in practicing 5As is 0.88, respectively.
Discussion
We observed that, in half a year, physicians reported that
the new subsidization policy in Taiwan resulted in an in-
creased number of patients, better prescription of medica-
tions, improved patient adherence, and improved quality
Table 2 The impact of the new subsidization policy to smoking cessation services
Impact Strongly disagree &
disagree
Neutral Agree & strongly
agree
n (%) n (%) n (%)
Patient changes
Increase in the number of smoking cessation patients 58 (9.6) 31 (5.1) 516 (85.3)
Increase in follow-up visits of smoking cessation patients 206 (34.0) 147 (24.3) 252 (41.6)
Increase in patients’ willingness to adopt pharmacotherapy for smoking cessation 145 (24.0) 127 (21.0) 333 (55.0)
Increase in the number of smoking cessation patients referred by other patients 173 (28.6) 175 (28.9) 256 (42.4)
Increase in patients’ abstinence rate 129 (21.3) 176 (29.1) 299 (49.6)
Physician’s attitudes towards the new policy
The new policy encourages more patients to quit smoking 113 (18.7) 130 (21.5) 362 (59.8)
The new policy helps me to prescribe smoking cessation medications 71 (11.7) 112 (18.5) 422 (69.8)
The new policy improves patients’ adherence to medications 116 (19.2) 173 (28.6) 315 (52.1)
The new policy improves quality of care 87 (14.4) 176 (29.1) 341 (56.5)
Overall, the new policy is an improvement over the previous policy 87 (14.4) 143 (23.6) 375 (61.9)
Possible barriers to the implementation of the new policy
Difficulties in providing services to inpatients and emergency room patients 77 (12.7) 304 (50.2) 222 (36.8)
Difficulties in tracking the abstinence rate of the patients 161 (26.6) 203 (33.6) 240 (39.8)
Difficulties in reimbursement and case report processes 162 (26.8) 270 (44.6) 172 (28.4)
Difficulties in applying for case management fees 138 (22.8) 265 (43.8) 201 (33.2)
Difficulties in using the information system 182 (30.1) 277 (45.8) 145 (24.0)
Changes in practicing 5As after the new policy
Increase in asking patients’ tobacco use status 85 (14.1) 245 (40.5) 274 (45.4)
Increase in advising patients to quit smoking 81 (13.4) 230 (38.0) 293 (48.5)
Increase in assessing patients’ willingness to quit 88 (14.5) 225 (37.2) 291 (48.2)
Increase in assisting patients to quit smoking 116 (19.2) 194 (32.1) 294 (48.7)
Increase in arranging follow-up visits 97 (16.0) 240 (39.7) 267 (44.2)
Table 3 Multiple regression models of summation indexes
Factor Patient changes Physician attitudes Possible barriers Practice a5As
ß p ß p ß p ß p
Physician’s age −0.03 0.045 −0.02 0.25 −0.01 0.89 −0.01 0.55
Physician’s gender: male 0.05 0.93 0.16 0.77 −0.23 0.55 0.88 0.06
Specialty: family medicine 0.68 0.03 0.57 0.09 0.19 0.42 0.35 0.22
Institution: medical center 2.94 0.001 3.36 0.001 1.13 0.06 2.34 0.001
Smoking status: non-smoker 0.07 0.89 0.45 0.37 −0.27 0.46 0.44 0.32
a5As: ask, advice, assess, assist, arrange
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of care. These changes were in accordance with the re-
duced medication cost to the patients. The impact was
more prominent in medical centers, and being a family
physicians was also associated with overall ratings in pa-
tient changes.
There is substantial evidence for the efficacy of finan-
cial incentives for smoking cessation. In a Cochrane re-
view, financial interventions had a favorable effect on
abstinence at 6 months (Relative risk, RR: 2.45, 95 %
confidence interval, CI 1.17 to 5.12), the number of par-
ticipants making an attempt to quit (RR: 1.11, 95 % CI
1.04 to 1.32) and the use of smoking cessation treatment
(RR: 1.83, 95 % CI 1.55 to 2.15) [15]. The incentive of re-
imbursement was the most significant factor affecting
physicians’ confidence and adherence to practice guide-
lines [12]. In Taiwan, the cost barrier was partially re-
moved in 2002, when the Taiwanese government became
the second in the world to reimburse smoking cessation,
just behind England. In a cost-benefit analysis evaluating
the Taiwanese smoking cessation services, the benefits
far exceeded the costs after accounting for the different
abstinence, relapse, and discount rates [16].
We proposed that if more than half (>50 %) of the
responding physicians agreed or strongly agreed with a
certain item, then such change was meaningful. It is
worth noting that 52.9 % of the physicians agreed that
the expenditure on smoking cessation medications in-
creased after the introduction of the new policy. Vareni-
cline, a relatively new pharmacotherapy for smoking
cessation [17], confers a higher abstinence rate of up to
three years [18]. Varenicline is also more costly. Sueh et
al. report that among U.S. Medicare beneficiaries,
greater varenicline out-of-pocket expense is significantly
associated with lower adherence and lower likelihood of
receiving a refill (odds ratio, OR: 0.59, 95 % CI 0.54 to
0.66) [17]. Under the SCPS in Taiwan, physicians have
more freedom to prescribe appropriate medication ac-
cording to individual needs rather than being restricted
by pharmaceutical prices. The prescription of varenicline
increased dramatically after the introduction of SCPS. It
is suggested that the increased abstinence rate may be
associated with the increased use of varenicline [14]. In
a way, the new policy has achieved its main goal: to re-
move the economic inequality.
The new policy has resulted in rises in the number of
clinical visits and patients using smoking cessation ser-
vices. More than four-fifths of physicians agreed or
strongly agreed that the most striking change brought
about by the new policy was an increase in patients.
Case numbers increased by 41 % after the implementa-
tion of the new policy [13].
Although the new policy has moderately changed the
practice of the 5As, physicians in medical centers took a
more positive attitude towards the new policy. This is
probably because medical centers are more apt to allo-
cate human resources to smoking cessation services, in-
cluding physicians, case managers, and professional
counselors. Medical centers also experienced greater
changes with respect to the domains of patient changes,
physicians’ attitudes and practice of the 5As. The med-
ical centers in Taiwan are different from those in the
western countries. A medical center not only provides
intensive care, cancer treatment and specialty consulta-
tions, it also provides large volume of outpatient ser-
vices. A patient may walk in a medical center without
referral. Therefore, the medical centers in Taiwan may
provide more accessibility to smoking cessation services
as compared to those in many western countries.
The majority of the physicians were neutral about pos-
sible barriers to the new policy, probably because the
smoking cessation service has been in operation since
2002. Physicians are already familiar with the computer-
ized information system and have little difficulties in
using it. Physicians in hospitals experience more difficul-
ties in providing services to inpatients and emergency
room patients. Though the new policy extends services
to these two patient groups, there are greater barriers of
implementation.
We recruited physicians who might have higher levels
of performance and self-efficacy in assisting patients to
quit smoking. Physicians with better confidence might
be more compliant with practice guidelines [19]. Just like
Table 4 The impact of new subsidization policy to institutional changes in different levels of medical settings
Impact Total (n = 605) Primary care
settings (n = 463)
Community
hospitals (n = 56)
Regional
hospitals (n = 61)
Medical
centers (n = 25)
p
n (%) n (%) n (%) n (%) n (%)
Increase in smoking cessation clinics 167 (27.6) 125 (27.0) 15 (26.8) 15 (24.6) 12 (48.0) 0.134
Increase in physicians providing
smoking cessation services
113 (18.7) 66 (14.3) 16 (28.6) 14 (23.0) 17 (68.0) <0.001
Increase in expense of smoking
cessation medications
320 (52.9) 249 (53.8) 25 (44.6) 31 (50.8) 15 (60.0) 0.515
Increase in case managers in charge
of the follow-up of patients
97 (16.1) 58 (12.6) 14 (25.0) 15 (24.6) 10 (40.0) <0.001
Increase in professional counselors 76 (12.6) 42 (9.1) 10 (17.9) 13 (21.3) 11 (44.0) <0.001
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previous surveys, family physicians were more likely to
respond than internists [12], probably due to more train-
ing in counseling skills [20]. Family physicians also expe-
rienced more favorable patient changes. Younger
physicians who have undergone newer training programs
might be more familiar with the issue of smoking cessa-
tion. Ulbricht S et al. reported younger general practi-
tioners provided more smoking cessation counseling
[21]. In our study, younger physicians reported more pa-
tient changes compared to their older peers.
This study has certain strengths. We obtained a na-
tionwide representative list of physicians providing
smoking cessation services. Our study might more
accurately reflect the true picture of daily practice in
different medical settings than previous studies. To in-
crease response rate, we allowed for different ways of
responding. It is well recognized that Taiwanese physi-
cians are reluctant to answer questionnaires [12]. Com-
pared to similar surveys targeting physicians providing
smoking cessation services, which had a 38 % response
rate in 2007 or 6.7 % in 2011 (unpublished data), this
study had the highest response rate (45.9 %) among the
studies carried out by the Taiwan Association of Family
Medicine. We evaluated service changes as well as
changes at different institutional levels. As far as we
know, this is the first study to compare smoking cessa-
tion attributes across different medical settings.
Certain limitations existed, such as the presence of se-
lection bias. Our participants might be more in favor of
the new policy compared to non-respondents. There
were differences in baseline characteristics between re-
spondents and non-respondents, and the study’s conclu-
sions might not be generalizable to the whole population.
We were not able to achieve long-term follow up, particu-
larly with respect to the decline in smoking rates. We en-
rolled only physicians providing smoking cessation
services, who tend to be more supportive of policies that
favor such practices. The attitude of physicians not en-
rolled in smoking cessation services remains unknown.
The Chinese culture makes people tend to choose the
“right” answer rather than the objective truth, therefore,
we might have overestimated the positive effects of the
new policy.
Future studies may include physicians who are less en-
gaged in smoking cessation services, but play important
roles in tobacco control, such as pulmonologists and
cardiologists. Future studies may also focus on cost-
benefit analysis, or the influence of more expensive
treatments such as varenicline and combination nicotine
replacement therapy. Since this study was carried out
shortly after the implementation of the new policy, it is
not known whether the attitudes of physicians would
change over time. Potential changes in physician atti-
tudes could be examined in future longitudinal studies.
Conclusions
We observed that the Second-generation Cessation
Payment Scheme in Taiwan improved smoking cessation
services. Overall, physicians agreed that the effects of the
new policy were positive. The enactment of the new reim-
bursement policy seems to have attained its goal of pro-
moting smoking cessation in the short term. Subsequent
follow up is mandatory to evaluate the long-term effects.
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